Metabolomx has developed a breathalyzer that can diagnose lung cancer in humans. Traditionally to determine if a patient has a lung cancer, doctors are often required to perform a biopsy that can be a costly procedure. With Metabolomx’s new device, the process is non-invasive and each test only costs $75.
The machine is able to detect the chemical signature pattern of the cancer after the patient breathes into the device for five minutes. In a recent clinical trial, the machine was able to detect lung cancer with an 83% accuracy. Metabolomx is also looking to expand the the analysis beyond cancer to other diseases as well.